Literature DB >> 30874429

Efficient Intracellular Delivery of RNase A Using DNA Origami Carriers.

Shuai Zhao1,2,3, Fangyuan Duan1, Shaoli Liu1,2, Tiantian Wu1,2, Yingxu Shang1,2,3, Run Tian1,2, Jianbing Liu1, Zhen-Gang Wang1, Qiao Jiang1, Baoquan Ding1,2,4.   

Abstract

Delivery of proteins to carry out desired biological functions is a direct approach for disease treatment. However, protein therapy is still facing challenges due to low delivery efficiency, poor targeting during trafficking, insufficient therapeutic efficacy, and possible toxicity induced by carriers. Here, we present a novel delivery platform based on DNA origami nanostructure that enables tumor cell transportation of active proteins for cancer therapy. In our design, cytotoxic protein ribonuclease (RNase) A molecules are organized on the rectangular DNA origami nanosheets, which work as nanovehicles to deliver RNase A molecules into the cytoplasm and execute their cell-killing function inside the tumor cells. Cancer cell-targeting aptamers are also integrated onto the DNA origami-based nanoplatform to enhance its targeting effect. This DNA origami-protein coassembling strategy can be further developed to transport other functional proteins and therapeutic components simultaneously for synergistic effects and be adapted for integrated diagnostics and therapeutics.

Entities:  

Keywords:  DNA origami; RNase A; cancer therapy; protein delivery; self-assembly

Mesh:

Substances:

Year:  2019        PMID: 30874429     DOI: 10.1021/acsami.8b21724

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  12 in total

1.  Strategic Insights into Engineering Parameters Affecting Cell Type-Specific Uptake of DNA-Based Nanomaterials.

Authors:  Marianna M Koga; Alice Comberlato; Hugo J Rodríguez-Franco; Maartje M C Bastings
Journal:  Biomacromolecules       Date:  2022-05-31       Impact factor: 6.978

2.  Design strategies for programmable oligonucleotide nanotherapeutics.

Authors:  Fitsum Feleke Sahle; Tao L Lowe
Journal:  Drug Discov Today       Date:  2019-09-13       Impact factor: 7.851

Review 3.  Artificial Organelles: Towards Adding or Restoring Intracellular Activity.

Authors:  Roy A J F Oerlemans; Suzanne B P E Timmermans; Jan C M van Hest
Journal:  Chembiochem       Date:  2021-03-04       Impact factor: 3.164

4.  A genipin-crosslinked protein-polymer hybrid system for the intracellular delivery of ribonuclease A.

Authors:  Xiao Liang; Xiuhui Tang; Jiebing Yang; Jiayuan Zhang; Haobo Han; Quanshun Li
Journal:  Int J Nanomedicine       Date:  2019-09-10

Review 5.  Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents.

Authors:  Jessica Castro; Marc Ribó; Maria Vilanova; Antoni Benito
Journal:  Pharmaceutics       Date:  2021-01-09       Impact factor: 6.321

Review 6.  Applications of DNA-Functionalized Proteins.

Authors:  Zhaoqiu Gong; Yuanyuan Tang; Ningning Ma; Wenhong Cao; Yong Wang; Shuang Wang; Ye Tian
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

7.  Nano-Scaled Zeolitic Imidazole Framework-8 as an Efficient Carrier for the Intracellular Delivery of RNase A in Cancer Treatment.

Authors:  Jiaxin Jia; Shudi Zhang; Kai Wen; Quanshun Li
Journal:  Int J Nanomedicine       Date:  2019-12-19

Review 8.  Rationally Designed DNA Nanostructures for Drug Delivery.

Authors:  Fan Xu; Qing Xia; Pengfei Wang
Journal:  Front Chem       Date:  2020-09-24       Impact factor: 5.221

9.  Mutations in artificial self-replicating tiles: A step toward Darwinian evolution.

Authors:  Feng Zhou; Ruojie Sha; Heng Ni; Nadrian Seeman; Paul Chaikin
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-14       Impact factor: 11.205

10.  CRISPR-Cas9-mediated nuclear transport and genomic integration of nanostructured genes in human primary cells.

Authors:  Enrique Lin-Shiao; Wolfgang G Pfeifer; Brian R Shy; Mohammad Saffari Doost; Evelyn Chen; Vivasvan S Vykunta; Jennifer R Hamilton; Elizabeth C Stahl; Diana M Lopez; Cindy R Sandoval Espinoza; Alexander E Deyanov; Rachel J Lew; Michael G Poirer; Alexander Marson; Carlos E Castro; Jennifer A Doudna
Journal:  Nucleic Acids Res       Date:  2022-02-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.